Microbicide acceptability among high-risk urban U.S. women: Experiences and perceptions of sexually transmitted HIV prevention

Sexually Transmitted Diseases

Volumn 31, Issue 11, 2004, Pages 682-690

  Weeks, Margaret R ^a   Mosack, Katie E ^a   Abbott, Maryann ^a   Sylla, Laurie Novick ^b   Valdes, Barbara ^a   Prince, Mary ^a  

^a INSTITUTE FOR COMMUNITY RESEARCH   (United States)

^b YALE UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CONTRACEPTIVE AGENT;

CONDOM; CONTRACEPTION; ETHNIC DIFFERENCE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RELATION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; REVIEW; SEXUAL ABUSE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; URBAN AREA; VIOLENCE;

ADMINISTRATION, INTRAVAGINAL; ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; CONNECTICUT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; SEXUALLY TRANSMITTED DISEASES; URBAN HEALTH; WOMEN'S HEALTH;

EID: 7044247335     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000143113.04524.a5     Document Type: Review

References (39)

1. HIV/AIDS Surveillance Report. Atlanta: Centers for Disease Control and Prevention; 2002.
2. AIDS Epidemic Update: Joint United Nations Programme on HIV/AIDS and World Health Organization. Available at: http://www.unaids.org/worldaidsday/ 2002/press/Epiupdate.html. December 2002.
3. Darroch JE, Frost JJ. Women's interest in vaginal microbicides. Fam Plann Perspect 1999; 31:16-23.
4. Elias CJ, Coggins C. Female-controlled methods to prevent sexual transmission of HIV. AIDS 1996; 10(suppl 3):S43-51.
5. International Working Group on Vaginal Microbicides. Recommendations for the development of vaginal microbicides. AIDS 1996; 10:1-6.
6. Potts M. The urgent need for a vaginal microbicide in the prevention of HIV transmission. Am J Public Health 1994; 84:890-891.
7. Rosenberg MJ, Gollub EL. Commentary: Methods women can use that may prevent sexually transmitted disease, including HIV. Am J Public Health 1992; 82:1473-1478.
8. Weeks MR, Schensul JJ, Williams SS, et al. AIDS prevention for African-American and Latina women: Building culturally and gender-appropriate intervention. AIDS Educ Prev 1995; 7:251-264.
9. Wainberg MA. The need for microbicides: why aren't women's groups more involved in the fight against AIDS? AIDS Res Hum Retroviruses 1999; 15:405-406.
10. Bentley ME, Morrow KM, Chesney M, et al. Acceptability research during a phase I trial of a new vaginal microbicide: BufferGel. In: National Conference on Women & HIV; 1997.
11. Bergeron MG, Roy S, Piret J, et al. Microbicidal gel to prevent the transmission of pathogens causing sexually transmitted diseases. In: Microbicides 2000 Conference; Washington, DC; 2000.
12. Chesney M, Bentley ME, Morrow KM, et al. Real experience: the key to vaginal microbicide acceptability. In: International Conference on AIDS; 1998;Vol 12:622.
13. Howett MK, Neely EB, Wigdhal B, et al. Sodium dodecyl sulfate - A potent vaginal microbicide. In: Microbicides 2000 Conference; Washington, DC; 2000.
14. Rencher W, Doncel G, Anderson RA, et al. Development of a new contraceptive/antimicrobial agent. In: Microbicides 2000 Conference; Washington, DC; 2000.
15. Population Council. Carraguard: A Microbicide in Development. New York: Population Council; 2002.
16. Harrison P, Rosenberg Z, Bowcut J. Topical microbicides for disease prevention: Status and challenges. Clin Infect Dis 2003; 36:1290-1294.
17. Gross M, Buchbinder SP, Celum C, et al. Rectal microbicides for US gay men: Are clinical trials needed? Are they feasible? Sex Transm Dis 1998; 25:296-302.
18. Bourne N, Stanberry L, Bernstein D. Pro 2000 gel reduces herpes simplex virus type 2 replication in the murine genital tract: An application in reducing transmission. In: Microbicide 2000 Conference; Washington, DC; 2000.
19. Johnston R. Microbicides 2002: An update. AIDS Patient Care 2002; 16:419-430.
20. McCormack S. Vaginal microbicides. Curr Opin Infect Dis 2002; 15:57-62.
21. Stone A. Microbicides: A new approach to preventing HIV and other sexually transmitted infections. Nature Reviews: Drug Discovery 2002; 1:977-985.
22. Hammett TM, Mason TH, Joanis CL, et al. Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: Results of product trials in three cities. Sex Transm Dis 2000; 27:119-126.
23. Hardy E, de Padua KS, Osis MJ, et al. Women's preferences for vaginal antimicrobial contraceptives. IV. Attributes of a formulation that would protect from STD/AIDS. Contraception 1998; 58:251-255.
24. Hardy E, Jimenez AL, de Padua KS, et al. Women's preferences for vaginal antimicrobial contraceptives. III - Choice of a formulation, applicator, and packaging. Contraception 1998; 58:245-249.
25. Hardy E, de Padua KS, Jimenez AL, et al Women's preferences for vaginal antimicrobial contraceptives. II - Preferred characteristics according to women's age and socioeconomic status. Contraception 1998; 58:239-244.
26. Hardy E, de Padua KS, Jimenez AL, et al. Women's preferences for vaginal antimicrobial contraceptives. I - Methodology. Contraception 1998; 58:233-238.
27. Severy LJ, McKillop K. Low-income women's perceptions of family planning service alternatives. Fam Plann Perspect 1990; 22:150-157, 168.
28. Soto RJ, Espinoza I, Baum M. Willingness of female sex workers to participate in HIV prevention intervention trials in Honduras. In: Microbicides 2000 Conference; Washington, DC; 2000.
29. Srirak N, Sirirojn B, Wichajarn M, et al. Acceptability of Thai males toward Buffergel as a vaginal microbicide in Chiang Mai, Thailand. In: Microbicides 2000 Conference; Washington, DC; 2000.
30. Singer M, Weeks MR. Hartford Target Sampling Plan: Community Alliance for AIDS Programs. Hartford, CT: Hispanic Health Council, Institute for Community Research; 1992.
31. Watters JK, Biernacki P. Targeted sampling-Options for the study of hidden populations. Soc Probl 1989; 36:416-430.
32. Borgatti S. Elicitation techniques for cultural domain analysis. In: The Ethnographer's Toolkit, vol. 3. London: AltaMira Press; 1999:115-151.
33. Borgatti S. Anthropac, 4.0 ed. Columbia, SC: Analytic Technologies; 1992.
34. Weeks MR, Grier M, Romero-Daza N, et al. Streets, drugs, and the economy of sex in the age of AIDS. Women Health 1998; 27:205-229.
35. Weeks MR, Grier M, Radda K, et al. AIDS and social relations of power: Urban African-American women's discourse on the contexts of risk and prevention. In: Elwood WN, ed. Power in the Blood: A Handbook on AIDS, Politics, and Communication. Mahwah, NJ: Lawrence Erlbaum Press; 1999:181-197.
36. Weissman G, Brown V, Consortium NAR. Drug use and sexual behavior among sex partners of injecting drug users-United States, 1980-1990. MMWR Morb Mortal Wkly Rep 1991; 40:855-860.
37. Worth D. Sexual decision-making and AIDS: Why condom promotion among vulnerable women is likely to fail. Stud Fam Plann 1989; 20:297-307.
38. Watts C, Kumaranayake L, Vidkerman P, et al. New Hope for HIV Prevention: Projections of the Impact of Microbicides. Antwerp, Belgium; May 2002.
39. Foss AM, Vickerman PT, Heise L, et al. Shifts in condom use following microbicide introduction: Should we be concerned? AIDS 2003; 17:1227-1237.